Link to website: http://www.bioprospect.com
BPO has been primarily involved in conducting research and early stage commercialisation activities in the pesticide and agricultural sectors.
AGRIPRO® is BioProspect's brand for its animal health and nutrition products, including GI-GUARD® products for gastro-intestinal care and AGRIPRO® products for other topical and general health care applications in animals.The global market for over the counter animal health products exceeds $15 billion a year, with more than 40% spent in the companion animal segment, including horses.
However, with the purchase of Re Gen Wellness Products Pty Ltd in August 2009 the group has also entered the human health and skin care market segment.
Re Gen Wellness Products Pty Ltd was acquired by BioProspect in August 2009, and is a wholly owned subsidiary of BPO. The business comprises a range of innovative health and wellness products, utilising the beneficial properties of natural compounds including plant extracts and emu oil.
It also incorporates highly effective topically applied products based on a unique blend of natural ingredients, providing the unique Transdermal Solvency® to enhance therapeutic pain relief and skin regenerative actions.
It also incorporates highly effective topically applied products based on a unique blend of natural ingredients, providing the unique Transdermal Solvency® to enhance therapeutic pain relief and skin regenerative actions.
Where are they now?
The company received a Government grant for two consecutive years to introduce the product into the Asian market. Unfortunately, the ReGen Wellness product line which proved to be
quite successful when they purchased the trademark has declined over the years
and the company now has disposed of its health care raw material and
product.
The company has maintained it’s intellectual property
including local and international trademarks with a view to either resuming
activities or selling the asset to another industry participant.
TERMILONE® is the registered Trade Mark for the natural Eremophilone Oil which is proven to be a natural solution to termites. For further information, the following is a very interesting video and article.
https://www.youtube.com/watch?v=jgvX9Wo2JgQ
http://www.bioprospect.com/index.php/our-projects/22-termilone
TERMILONE® is the registered Trade Mark for the natural Eremophilone Oil which is proven to be a natural solution to termites. For further information, the following is a very interesting video and article.
https://www.youtube.com/watch?v=jgvX9Wo2JgQ
http://www.bioprospect.com/index.php/our-projects/22-termilone
In March, 2014 BPO signed a Licence Deed with the University of Western Sydney (UWS). The agreement will enable Termilone to be included in a proposed project to investigate the use of natural insecticide products in cotton. For further information please go to the following link:
http://www.smh.com.au/business/markets/quotes/announcement/BPO/bioprospect-limited/1498826
http://www.smh.com.au/business/markets/quotes/announcement/BPO/bioprospect-limited/1498826
On 8 July 2011 at an extraordinary general meeting of
shareholders, approval was given to change for the Company to include in its activities
the exploration, development and production of oil and gas domestically and
internationally and as well as other associated activities. This investment opportunity was in line with the
Company’s strategy of increasing shareholder value.
Qcide® is being developed as a new, environmentally friendly treatment for household and agricultural pests. Qcide® is based on Tasmanone, a natural insecticide derived from the leaves of Eucalyptus cloeziana, common name Gympie Messmate, a forest tree species found in areas of Queensland.
The active molecule in oil from the leaves of Eucalyptus cloeziana is Tasmanone, a β-triketone which exhibits a unique mode of action thought to be targeting the octopermine receptor in insects. This has been identified as the basis for a use patent and for commercialisation of the compound as an insecticide with applications in urban pest control, crop protection and animal health.
In January 2010, BioProspect announced an IP Assignment Deed with Bio-Gene Technology Ltd (Bio-Gene) and UWS which granted ownership of the Tasmanone IP to Bio-Gene, in exchange for fees and royalties split between BioProspect and UWS.
For more information on Qcide® and Bio-Gene, refer to http://www.bio-gene.com.au
The Future for BPO:
Continue
to evaluate new business opportunities consistent with BioProspect’s long term
strategy to grow market value through the development of biotechnologies.
This comment has been removed by the author.
ReplyDeleteHi Rae. Great blog. It's been interesting to read that companies readily diversify into other areas to increase shareholder profit. It appears that diversification is an essential component in long term growth. Can't wait to read more. (Sorry about the deletion - had to correct my spelling!).
DeleteHi Rae,
ReplyDeleteGreat Blog found it very informative,
will follow with interest.
Cheers Scott.